By Amanda Ganiszewski, Editorial Intern and Carrie Capili, Communications Specialist, Editor
Globally, the National Comprehensive Cancer Network® (NCCN®) works in collaboration with third party organizations to present the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) to international audiences of clinicians and other medical professionals. Additionally, NCCN collaborates to create and distribute International Adaptations and Translations of the NCCN Guidelines™, which may include modifications representative of metabolic differences in populations, technological considerations, and regulatory status of agents used in cancer management, such as availabilities of drugs, biologics, devices, and procedures.
Demand has increased for the development and publication of foreign editions of the NCCN Guidelines. The foreign editions of NCCN Guidelines are developed by the host country’s oncology thought leaders in conjunction with NCCN Guidelines Panel Members. Modified NCCN Guidelines are published and distributed locally to aid clinicians in determining appropriate and effective avenues of care.
To date, the NCCN Guidelines have been translated and adapted into such languages as Chinese, German, Italian, Japanese, Korean, Polish, Portuguese, Russian, Spanish, and Turkish. Select NCCN Guidelines in Chinese, Japanese, Korean, and Spanish are available on NCCN.org.
Approximately 44 percent of registered users of the NCCN Guidelines, NCCN Drugs & Biologics Compendium (NCCN Compendium™), and the NCCN Chemotherapy Order Templates (NCCN Templates™) reside outside the United States, illustrating that the interest and implementation of NCCN resources in the global community continues to flourish.To learn more about the international adaptations and translations of the NCCN Guidelines, visit NCCN.org/international. If you have questions about NCCN international programs or adaptations and translations of the NCCN Guidelines, please contact Kelly Simpson, Manager, Global Initiatives.